REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
09/01/2025
Back to search
Official data from USPTO
AVET PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
18
Latest update
09/02/2025
Trademark type
Word
Nice classes
5
Filing date
02/06/2020
Registration date
09/01/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/01/2020
Last transaction
09/02/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
01/29/2020
First use in commerce
01/29/2020
Drawing code
4
Owner type
03
Owner location
East Brunswick, NJ
Examiner
SMIGA,HOWARD
Law office
L20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Heritage Pharmaceuticals Inc.
Representatives
MATTHEW A. HOMYK BLANK ROME LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of neurologicalrenalhematopoieticthyroidophthalmic diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Anti-inflammatory pharmaceutical preparations; Cardiovascular pharmaceuticals; anti-microbial pharmaceutical preparations; anti-neoplastic pharmaceutical preparations; immunomodulatory pharmaceutical preparations; hematopoietic pharmaceutical preparations; Pharmaceutical preparationsanticoagulants; pharmaceutical preparationsthrombolytic agents; antiplateletsplatelet agglutination inhibitors and platelet aggregation inhibitors; Estrogen preparations; pharmaceutical preparationsprogestin; Androgen preparations; Antithyroid pharmaceutical preparations used to treat hyperthyroidism; Pharmaceutical preparations for treating diabetes; pharmaceutical preparationshistamine H2 receptor antagonists and proton pump antagonists; anti-emetic pharmaceutical preparations; anti-convulsant pharmaceutical preparations; pharmaceutical preparations for the treatment of asthma; anti-diabetic pharmaceuticals
Publications
History of USPTO decisions and trademark events.
18 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
09/01/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/16/2020
PUBO
PUBLISHED FOR OPPOSITION
06/16/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/27/2020
ALIE
ASSIGNED TO LIE
05/11/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/30/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
04/30/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/30/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
04/30/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/30/2020
GEAN
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
04/29/2020
GEAP
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
04/29/2020
EPEN
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
04/29/2020
CPEA
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
04/29/2020
DOCK
ASSIGNED TO EXAMINER
04/27/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/10/2020
NWAP
NEW APPLICATION ENTERED
02/10/2020
Continuous trademark protection
Get notified about every new filing that threatens AVET PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.